Meet the challenge, focus on Innovation -- 2020 dia China annual meeting will meet you in the summer of July

< br / > < br / > at the opening ceremony of the 2020 dia annual drug information conference and Exhibition on July 30, DrTeresa Mullin, head of the registration department of the State Food and Drug Administration of China and deputy director of the FDA CDER Strategic Initiative department, and Academician Wang Chen, vice president of the Chinese Academy of engineering, will come to discuss how to realize the patient-centered regulatory system, And how clinical research institutions cooperate with pharmaceutical enterprises to accelerate the thinking of drug innovation and R & D to give keynote speech< br / > in the following special forum session of the opening ceremony, representatives of overseas regulators, researchers, domestic innovative pharmaceutical companies, investors and consulting companies will also be invited to discuss how China's innovative drugs can steadily move to the world and affect the new pattern of global drug development< br / > deadline for online registration: July 17 < br / > < br / > < br / > < br / > < br / > < br / > < br / > < br / > < br / > < br / > < br / / > this session of SFDA will be held at < br / > < br / > < br / > < br / > < br / > < br / > < br / > conference consultation: Ni Junting < br / > email: junting.ni @ DIAglobal.org < br / > < br / > Hotel Reservation: Tang Jingjing < br / > Tel: 15850577978 < br / > email: jing.tang @ dttrip.com < br / > < br / > Company Group report: Xie Fei < br / > Tel.: + 86.10.5704 2652 < br / > email: fei.xie @ DIAglobal.org < br / > < br / > exhibition and advertising opportunities: MrZheng Peng < br / > email: zhengpeng@ccfdie.orgzhangwanchen@ccfdie.org < br / > Tel.: + 86 10 8221 2866 * 6007 / 6005